REPORT FROM THE 133rd AMERICAN NEUROLOGICAL ASSOCIATION MEETING – Diabetes has been linked to cognitive decline arising from vascular damage and multi-infarct dementia, but new data suggest that diabetes may also contribute to the pathogenesis of Alzheimers disease.
Neurology
MoCA useful to assess cognitive function in Parkinsons disease
December 10, 2008REPORT FROM THE 133rd AMERICAN NEUROLOGICAL ASSOCIATION MEETING – The Montreal Cognitive Assessment (MoCA) appears to be more sensitive than the Mini Mental State Examination (MMSE) in detecting cognitive changes and may be useful in patients with Parkinsons disease.
Preliminary data for MS vaccines in development
November 25, 2008REPORT FROM THE WORLD CONGRESS ON TREATMENT AND RESEARCH IN MS – A number of different vaccine formulations are currently in development for MS.
Read More
Low vitamin D implicated in MS
November 25, 2008REPORT FROM THE WORLD CONGRESS ON TREATMENT AND RESEARCH IN MS – Vitamin D levels are frequently low in children and may be a risk factor for multiple sclerosis, according to two studies presented at the World Congress.
Emerging MS therapies Part II
November 25, 2008REPORT FROM THE WORLD CONGRESS ON TREATMENT AND RESEARCH IN MS – A number of new therapies are currently in development for the treatment of MS. In part two of this two-part article, we summarize the most recent data presented at the World Congress. (See Emerging MS therapies Part I for information on cladribine, teriflunomide and fingolimod.)
Read More